Teladoc Health Inc
For the period ended May 23, 2024. Filed Apr 9, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 23, 2024 · Filed Apr 9, 2024
Contents
Proxy summary
This summary contains highlights about Teladoc Health, Inc. (“Teladoc Health,” the “Company” or “we”) and its upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”). This summary does not contain all of the information that you should consider in advance of the meeting, and we encourage you to read the entire proxy statement carefully before voting.
2024 Annual meeting
| When | Virtual meeting | Record date | |||
| Thursday, May 23, 20242:00 p.m. EDT | www.virtualshareholdermeeting.com/TDOC2024 | March 28, 2024 |
|---|
| Voting matters · Boardrecommendations · For more information,see page | |||
|---|---|---|---|
| 1 | Election of eight director nominees | FOR each nominee | 10 |
| 2 | Advisory vote to approve executive compensation (Say-on-Pay) | FOR | 27 |
| 3 | Advisory vote to approve the frequency of future advisory votes on the compensation of Teladoc Health’s named executive officers | 1 YEAR | 69 |
| 4 | Ratification of the selection of Ernst & Young LLP as independent auditors for 2024 | FOR | 70 |
| 2024 Proxy Statement | Teladoc Health | 1 |
|---|
Proxy summary
2023 Performance and company highlights
Executing our 2023 priorities:
| $2.6B | $328M(1) | $194M(1) |
|---|---|---|
| Revenue growth of 8% | Adjusted EBITDA growth of 33% | Free cash flow, up from $17M |
| $1.5B | $1.1B | 1.2M |
| U.S. integrated care revenue, up 7% | BetterHelp revenue, up 11% | Chronic care program enrollment, up 14% |
(1)For a full reconciliation of (i) net loss, the most directly comparable GAAP financial measure, to adjusted EBITDA and (ii) net cash provided by operating activities, the most directly comparable GAAP financial measure, to free cash flow, please see the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Consolidated Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
| 2 | Teladoc Health | 2024 Proxy Statement |
Proxy summary
Human capital management and diversity, equity and inclusion
At Teladoc Health, we live our values as a company through policies, governance, and deliberate investment in operating responsibly and sustainably. We are committed to making a positive impact in society and, perhaps even more importantly, to encourage others of like mind and spirit to join us in this critical work.
To fulfill our mission, we are focused on building a great company that becomes a global destination for amazing talent who want to build their careers, develop their capabilities, and grow both professionally and personally. We design a range of programs and initiatives to:
nurture talent
encourage curiosity and innovation
make room for diverse voices and perspectives
increase engagement and connectiveness
mentor leaders for future roles
We build a range of total reward programs that support employees through fair, equitable, and competitive pay and benefits, and we invest in technology, tools and resources to transform and increase the quality of work.
We continue to look for ways to expand a range of programs and initiatives that are focused to attract, develop and retain our workforce—including a focused engagement through diversity, equity, and inclusion (“DEI”). We have enhanced our talent efforts in recent years to include:
| Supporting Employees Through Our Products and Services | Talent Development | Business Resource Groups | |||
| We offer our employees full access to our diverse portfolio of whole-person health solutions, including:•free mental health resources•digital health devices•on-demand access to the employee assistance program for employees and their dependents | We prioritize and invest in creating opportunities to help employees grow and build their careers, through training and development programs. These include:•online and self-paced courses•live in-class education•professional speaker series•peer-to-peer learning•certification programs•on-the-job training•executive talent and succession planning paired with an individualized development approach | We believe our business resource groups (“BRGs”), are a foundational element of the DEI ecosystem. Our seven BRGs include a focus on LGBTQ+, women, multicultural, military veterans, neurodiversity and differing physical and mental abilities, working parents and caregivers, and generational interests of employees who are engaged in four key pillars:•Building internal community/network•Advancing external community•Supporting business impact•Enhancing professional development | |||
|---|---|---|---|---|---|
| Community Impact | |||||
| We embrace the opportunity and the responsibility to have a meaningful impact in our global community, using our voice and our resources to help expand equitable access to care, and create a better future for families and our neighbors. We continue to work toward further mobilizing our workforce to give back to the communities where we live and work through new volunteer programs and corporate matching opportunities for giving.We set out to advance positive social change in our communities with a 2023 achievement of volunteering more than 13,000 hours around the globe. This was a monumental achievement that was consistent with our values, including those of respecting and taking care of people, doing what’s right, and succeeding together. For 2024, we have continued to challenge ourselves and set goals for volunteer hours to do good and give back to our communities. | |||||
| 2024 Proxy Statement | Teladoc Health | 3 |
|---|
Proxy summary
| Expanding the Voice of the Employee | Open Dialogue to Encourage Diverse Thinking and Voices | Focusing on Diversity Recruiting and Talent Acquisition | |||
| We strive to build a culture of inclusion which includes regularly soliciting employee feedback through our pulse engagement surveys, listening circles and seeking opportunities to advance employee feedback. | We have invested in our employees and broadened our external speaker series, interactive expert discussions, and self-paced learning programs to expand knowledge and awareness of diversity and health topics. | We continue to broaden our diversity hiring manager training resources for performance-based interviewing, which included a screening tool to promote gender-neutral job descriptions.We expanded our corporate and college/university partnerships to advance our pipeline of diverse talent. |
|---|
Building stronger, healthier communities
We aim to do more than improve the healthcare experience. From our boots-on-the-ground efforts to our reform-on-the-Hill initiatives, we also strive to enhance the lives of the people and communities we serve.
In the aftermath of a natural disaster, urgent care and doctors’ offices can be slow to reopen due to power outages or damages. This year, we enabled free visits for communities recovering from natural disasters all across the U.S., helping families get access to necessary prescriptions and care. In addition, BetterHelp’s social good program enabled thousands of hours of free therapy for communities in need—from Ukraine to the Middle East.
In 2023, we completed disaster missions to support relief in eight states reeling from hurricanes and other natural events.
Wildfiresin Hawaii
Mudslidesin California
Tornadosin Arkansas, Mississippiand Tennessee
Hurricane Idaliain Florida, Georgia and South Carolina
| 4 | Teladoc Health | 2024 Proxy Statement |
Proxy summary
Health equity
Our commitment to health equity is central to our mission of empowering all people everywhere to achieve their healthiest lives. We continue to make targeted investments to advance health equity by capturing and leveraging actionable data, designing for equity in our products and services, supporting the social drivers of health, and contributing to the industry's collective progress in this area via partnerships and collaboration.
As health equity increasingly becomes a regulatory and market differentiating reality for our Clients, Teladoc Health remains well positioned to meet the diverse needs, preferences, and circumstances of those whom we collectively serve. Our size, scale, and quality infrastructure enable us to continually assess and improve our services in order to deliver equitable access, experiences, and outcomes for all.
Corporate governance highlights
Corporate Governance Best Practices
Annual election of directors
2 of our director nominees are women
1 of our director nominees is ethnically/racially diverse
All of our director nominees are independent
Independent Board chair
Balance of new and experienced directors
No overboarding
Annual director self-evaluation and committee assessment to ensure Board effectiveness
Multiple members of our Audit Committee qualify as “audit committee financial experts”
All current directors attended at least 75% of 2023 meetings
Regular executive sessions of independent directors
Majority voting standard in uncontested elections
Stockholder ability to call special meetings
Proxy access (3/3/20/25)
Enterprise Risk Management program to oversee organizational risk
Code of Business Conduct and Ethics
Annual Say-on-Pay vote
Independent compensation consultant
Pay-for-performance philosophy
Stock ownership guidelines for directors and executives
No hedging or pledging of company stock
Clawback policy
Active stockholder engagement
Commitment to corporate social responsibility
| 2024 Proxy Statement | Teladoc Health | 5 |
|---|
Proxy summary
Board of directors overview
Director nominees
| Director nominee and principal occupation · Age · Director since · Independent · Current committee membership | ||||||||
|---|---|---|---|---|---|---|---|---|
| AC · CC · NCGC · QCPSC · EC | ||||||||
| J. Eric Evans(1)Chief Executive Officer, Surgery Partners | 47 | 2023 | ||||||
| Sandra L. FenwickRetired Chief Executive Officer, Boston Children’s Hospital | 73 | 2020 | ||||||
| Catherine A. Jacobson(2)Chief Executive Officer, Froedtert ThedaCare Health | 60 | 2020 | ||||||
| Thomas G. McKinley(3)General Partner,Cardinal Partners | 72 | 2009 | ||||||
| Kenneth H. PaulusRetired President and Chief Executive Officer, Prime Therapeutics | 64 | 2017 | ||||||
| David L. ShedlarzRetired Vice Chairman, Executive Vice President and CFO, Pfizer | 75 | 2016 | ||||||
| Mark Douglas Smith, M.D., MBAClinical Professor of Medicine, University of California at San Francisco; and a board-certified internist | 72 | 2018 | ||||||
| David B. Snow, Jr. Chairman and Chief Executive Officer, Cedar Gate Technologies | 69 | 2014 | ||||||
| Meetings in 2023 | Board - 10 | 5 | 5 | 7 | 4 | 0 | ||
| Committee chair | Committee member | A | Audit committee financial expert | ||
| AC | Audit | NCGC | Nominating & corporate governance | EC | Executive |
|---|---|---|---|---|---|
| CC | Compensation | QCPSC | Quality of care & patient safety | ||
(1)Mr. Evans is expected to serve as Chair of the Compensation Committee and as a member of the Audit Committee and the Executive Committee following the Annual Meeting.
(2)Ms. Jacobson is also expected to serve as a member of the Quality of Care and Patient Safety Committee following the Annual Meeting.
(3)Mr. McKinley is expected to continue to serve as a member of the Compensation Committee and to serve as a member of the Audit Committee following the Annual Meeting. He is expected to leave the Executive Committee concurrently with Mr. Evan’s appointment as Chair of the Compensation Committee.
| 6 | Teladoc Health | 2024 Proxy Statement |
Proxy summary
Board attributes
Our director nominees compose a well-balanced, diverse Board of Directors (the “Board”).
| Independence | Tenure | ||
|---|---|---|---|
| 100%Independent | 7yearsAverage tenure | ||
| Age | Diversity | ||
| 67yearsAverage age | 38%Diverse |
| 2024 Proxy Statement | Teladoc Health | 7 |
|---|
Proxy summary
Board refreshment
Three of our independent director nominees have joined our Board since 2020, representing 38% of our director nominees.
| 2020 | 2023 | |
| Sandra L. Fenwick | Catherine A. Jacobson | J. Eric Evans |
Key director skills and experience
This table summarizes the key skills, attributes and experiences of each of our director nominees that are most relevant to their board service. The fact that a specific area of focus or experience is not designated does not mean the director nominee does not possess that attribute or expertise.
| Academics | 2/8 | 25% |
|---|---|---|
| Audit and financial reporting | 4/8 | 50% |
| Corporate governance | 7/8 | 88% |
| Executive leadership | 8/8 | 100% |
| Finance and investment industry | 1/8 | 13% |
| Healthcare and medicine | 8/8 | 100% |
| Human capital management | 8/8 | 100% |
| Other public company board experience | 7/8 | 88% |
| Regulatory, government and compliance | 7/8 | 88% |
| Risk management | 8/8 | 100% |
| Strategic planning and operations | 8/8 | 100% |
| Technology and innovation | 4/8 | 50% |
| 8 | Teladoc Health | 2024 Proxy Statement |
Proxy summary
Executive compensation highlights
Our Compensation Committee has designed our executive compensation program in alignment with our key strategic priorities and commitment to aligning executive pay with corporate performance and stockholder interests. Accordingly, long-term incentives in the form of stock awards make up the significant majority of our named executive officers’ total target compensation such that their pay outcomes are directly linked to our stockholders’ experience.
Total 2023 target compensation mix
CEO
Average of other NEOs
Consideration of say-on-pay advisory vote
| •While the most recent Say-on-Pay vote indicates significant stockholder support of the philosophy, strategy and objectives of our executive compensation programs, the Compensation Committee recognizes the relative year over year decline in support and intends to seek to further align executive compensation with stockholder interests.•Following the annual review of our executive compensation philosophy by our Compensation Committee, as well as our most recent Say-on-Pay results and engagement with stockholders, our overall approach to executive compensation will not change. However, we have adjusted our compensation program in response to stockholder feedback by further emphasizing long-term performance periods for performance-based restricted stock units and altering our 2024 equity grant practices to reduce our burn rate.•The Compensation Committee will continue to monitor stockholder feedback, including the results of the annual Say-on-Pay vote, in making future decisions affecting our compensation programs. | SIGNIFICANT STOCKHOLDER APPROVAL OF SAY-ON-PAY OVER LAST 3 YEARS2021 – 87.2%2022 – 91.6%2023 – 81.9% |
|---|
| 2024 Proxy Statement | Teladoc Health | 9 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.